Events & Conferences

UPCOMING EVENTS & CONFERENCES

PAST EVENTS & CONFERENCES

20th Annual Meeting of the Immunology of Diabetes Congress (IDS 2024)

November 04-08, 2024
Bruges, Belgium

60th Annual Meeting European Association for the Study of Diabetes (EASD)

September 10-13, 2024
Madrid, Spain

84th Scientific Sessions American Diabetes Association

June 21-24, 2024
Orlando, USA

5th European Incretin Study Group Meeting

April 4-6, 2024
Cambridge, UK

2023 International Congress of Diabetes and Metabolism

October 19-21, 2023
Gyeongju, Republic of Korea

59th Annual Meeting European Association for the Study of Diabetes (EASD)

October 2-6, 2023
Hamburg, Germany
EndoC-βH5®: a highly functional human pancreatic beta cell that can model glucolipotoxicity and inflammatory responses

83th Scientific Sessions American Diabetes Association

June 23-26, 2023
San Diego, USA
EndoC-βH5® A Robust and Reliable Human Pancreatic Beta Cell Line for T1D and T2D Diabetes Modellings

Immunology of Diabetes Society

May 23-27, 2023
Paris, France

Société Francophone du Diabètes 2023

March 20-24, 2023
Montpellier, France

European Incretin Study Group Meeting

Sept 29th – Oct 1st, 2022
Lausanne, Switzerland
EndoC-βH5® human beta cells: a unique “thaw and go” model for accelerating Diabetes research with highly functional and ready-to-use human beta cells

58th Annual Meeting European Association for the Study of Diabetes (EASD)

Sep 19-23, 2022
Stockholm, Sweden
EndoC-βH5® human beta cells: a unique “thaw and go” model for accelerating Diabetes research with highly functional and ready-to-use human beta cells

European Islet Study Group Workshop

June 13-15, 2022
Strasbourg, France
EndoC-βH5® human beta cells: a unique “thaw and go” model for accelerating Diabetes research with highly functional and ready-to-use human beta cells

82nd Scientific Sessions American Diabetes Association

June 3-7, 2022
New Orleans, USA
EndoC-βH5® human beta cells: a unique “thaw and go” model for accelerating Diabetes research with highly functional and ready-to-use human beta cells